Standout Papers
Citation Impact
Citing Papers
The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia
2011 Standout
De novo design of picomolar SARS-CoV-2 miniprotein inhibitors
2020 StandoutScienceNobel
High-dose intravenous IgG for chronic idiopathic thrombocytopenic purpura in adults
1984
Treatment of autoimmune thrombocytopenic purpura with rhesus antibodies (anti-Rh0(D))
1984
High dose gammaglobulin therapy in adults with idiopathic thrombocytopenic purpura (ITP) clinical effects
1984
Interim evaluation of two cooperative studies assessing the effects of intravenous immunoglobulin (i.v. IgG) on childhood idiopathic thrombocytopenic purpura (ITP)
1984
Head and neck squamous cell carcinoma
2020 Standout
The Role of Glutathione and Glutathione S‐Transferases in Mercapturic Acid Biosynthesis
1969 Standout
Pharmacokinetic observations of phenytoin disposition in the newborn and young infant.
1977
Effectiveness of a hospital-wide programme to improve compliance with hand hygiene
2000 Standout
Intravenous high-dose igg therapy induced alterations of spleen lymphocyte igm secretion and t cell subsets in patients with idiopathic thrombocytopenic purpura
1987
Passive Immunotherapy in AIDS: A Randomized Trial of Serial Human Immunodeficiency Virus-Positive Transfusions of Plasma Rich in p24 Antibodies versus Transfusions of Seronegative Plasma
1992 StandoutNobel
A Randomized Trial of Maintenance Therapy for Vasculitis Associated with Antineutrophil Cytoplasmic Autoantibodies
2003 Standout
Evaluation of aspirin metabolites as inhibitors of hypoxia-inducible factor hydroxylases
2008 StandoutNobel
Acute immune thrombocytopenic purpura: A comparative study of very high oral doses of methylprednisolone and intravenously administered immune globulin
1994
Childhood ITP: 12 months follow‐up data from the prospective registry I of the Intercontinental Childhood ITP Study Group (ICIS)
2005
Myasthenia Gravis
2016 Standout
Treatment of childhood acute immune thrombocytopenic purpura with anti-D immune globulin or pooled immune globulin
1999
Manipulating the Immune System with Immune Globulin
1992
Experiences with recombinant FVIIa in the emergency treatment of patients with autoimmune thrombocytopenia: a review of the literature
2008
Small-Vessel Vasculitis
1997 Standout
The treatment of chronic idiopathic thrombocytopenia with anti-D (Rho) immunoglobulin: its effectiveness, safety and mechanism of action
1988
Plasma exchange and intravenous immunoglobulin treatment of neuromuscular disease
1994
Immunomodulatory action of intravenous immunoglobulin
2002
Long-Term Danazol Therapy in Autoimmune Thrombocytopenia: Unmaintained Remission and Age-Dependent Response in Women
1989
High dose intravenous methylprednisolone or high dose intravenous gammaglobulin for autoimmune thrombocytopenia
1988
Fc receptors and their interaction with complement in autoimmunity
2005
Low-Dose Versus High-Dose Immunoglobulin for Primary Treatment of Acute Immune Thrombocytopenic Purpura in Children: Results of a Prospective, Randomized Single-Center Trial
2003
Guillain-Barré syndrome
2016 Standout
Glycosylation in Cellular Mechanisms of Health and Disease
2006 Standout
Phototherapy for Neonatal Jaundice
2008 Standout
IgG Fc Glycosylation in Human Immunity
2019
The immunomodulatory effects of intravenous immunoglobulin therapy in Kawasaki disease
2015
Clinical trial of plasma exchange and high‐dose intravenous immunoglobulin in myasthenia gravis
1997
Mortality associated with Down's syndrome in the USA from 1983 to 1997: a population-based study
2002 Standout
Immunthrombocytopenic purpura as a model for pathogenesis and treatment of autoimmunity
1995
Treatment of Antineutrophil Cytoplasm Autoantibody-Associated Systemic Vasculitis: Initiatives of the European Community Systemic Vasculitis Clinical Trials Study Group
1997
Pharmacokinetic Effects of 4C9, An Anti-FcRn Antibody, in Rats: Implications for the Use of FcRn Inhibitors for the Treatment of Humoral Autoimmune and Alloimmune Conditions
2005
A Single Intravenous Infusion of Gamma Globulin as Compared with Four Infusions in the Treatment of Acute Kawasaki Syndrome
1991 Standout
Autoimmune Thrombocytopenic Purpura and Common Variable Immunodeficiency
2004
Combined plasma exchange and intravenous gammaglobulin in the treatment of patients with refractory immune thrombocytopenic purpura
1988
Intravenous immunoglobulin: regulatory perspectives on use and supply
2001
Immediate effects of intravenous IgG administration on peripheral blood B and T cells and polymorphonuclear cells in patients with myasthenia gravis
1988
Fcγ receptors as regulators of immune responses
2007 Standout
Myasthenia Gravis
1994 Standout
High-dose intravenous gammaglobulin therapy for neonatal autoimmune thrombocytopenia
1988
Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura
1994
A prospective, randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpura
1993
Oral Megadose Methylprednisolone Versus Intravenous Immunoglobulin for Acute Childhood Idiopathic Thrombocytopenic Purpura
1993
High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments.
1994
Efficacy of intravenous gammaglobulin therapy in chronic refractory polymyositis and dermatomyositis: An open study with 20 adult patients
1991
Mechanisms of action of intravenous immunoglobulin therapy and potential use in autoimmune connective tissue diseases
1991
Immune Thrombocytopenic Purpura
2002 Standout
Effect of intravenous immunoglobulin on steroid consumption in patients with severe asthma: A double-blind, placebo-controlled, randomized trial
1999
Graft-versus-host disease
2009 Standout
Potassium channel antibody‐associated encephalopathy: a potentially immunotherapy‐responsive form of limbic encephalitis
2004 Standout
High-dose dexamethasone as a first- and second-line treatment of idiopathic thrombocytopenic purpura in adults
2004
Experience with intravenous immunoglobulin in myasthenia gravis
1989
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
The biochemistry and toxicology of benzoic acid metabolism and its relationship to the elimination of waste nitrogen
1993
The trinity of COVID-19: immunity, inflammation and intervention
2020 Standout
Global strategy for asthma management and prevention: GINA executive summary
2007 Standout
Comparison of the efficacy of a two-day and a five-day schedule for infusing intravenous gamma globulin in the treatment of immune thrombocytopenic purpura in adults
1987
Immunomodulation by IVIg and the Role of Fc-Gamma Receptors: Classic Mechanisms of Action after all?
2015
Reevaluation of the prognostic factors for splenectomy in chronic idiopathic thrombocytopenic purpura (ITP): A report on 181 cases
1989
Increased surface expression of HIV-1 envelope is associated with improved antibody response in vaccinia prime/protein boost immunization
2017 StandoutNobel
Alternation of two doses of intravenous gammaglobulin in the maintenance treatment of patients with immune thrombocytopenic purpura: More is not always better
1990
Head and Neck Cancer: Global Burden and Regional Trends in India
2014
Fc receptor blockade and immune thrombocytopenic purpura
2000
Pulse methylprednisolone therapy for acute childhood idiopathic thrombocytopenic purpura
1988
Infusion of Fcγ fragments for treatment of children with acute immune thrombocytopenic purpura
1993
Intravenous immunoglobulin for adults with autoimmune thrombocytopenic purpura: results of a randomized trial comparing 0.5 and 1 g/kg b.w.
1999
Mechanism of therapeutic effect of high-dose intravenous immunoglobulin. Attenuation of acute, complement-dependent immune damage in a guinea pig model.
1989
Danazol for Children With Immune Thrombocytopenic Purpura
1988
Current usage of intravenous immune globulin and the rationale behind it: the Massachusetts General Hospital data and a review of the literature
2006
Neonatal Hyperbilirubinemia
2001 Standout
Guillain-Barr?? Syndrome
2004
Randomized trial comparing intravenous immunoglobulin with methylprednisolone pulse therapy in acute idiopathic thrombocytopenic purpura
1996
Polymyositis and dermatomyositis
2003 Standout
FcRn: the neonatal Fc receptor comes of age
2007 Standout
The antiinflammatory activity of IgG: the intravenous IgG paradox
2007
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
2017 Standout
A Single Dose of Anti-D Immunoglobulin Raises Platelet Count as Efficiently as Intravenous Immunoglobulin in Newly Diagnosed Immune Thrombocytopenic Purpura in Korean Children
2008
CLINICAL COURSE OF CHILDREN WITH IMMUNE THROMBOCYTOPENIC PURPURA TREATED WITH INTRAVENOUS IMMUNOGLOBULIN G OR MEGADOSE METHYLPREDNISOLONE OR OBSERVED WITHOUT THERAPY
2002
Intravenous immunoglobulin therapy: how does IgG modulate the immune system?
2013
Guillain-Barré syndrome
2005 Standout
Functional Roles of the IgM Fc Receptor in the Immune System
2019 StandoutNobel
A Controlled Trial of High-Dose Intravenous Immune Globulin Infusions as Treatment for Dermatomyositis
1993 Standout
Developmental Pharmacology — Drug Disposition, Action, and Therapy in Infants and Children
2003 Standout
Advances in understanding and treatment of immune‐mediated disorders of the peripheral nervous system
2004
Predictive Ability of a Predischarge Hour-specific Serum Bilirubin for Subsequent Significant Hyperbilirubinemia in Healthy Term and Near-term Newborns
1999 Standout
Danazol for the Treatment of Idiopathic Thrombocytopenic Purpura
1983
Anti-inflammatory Activity of IVIG Mediated Through the Inhibitory Fc Receptor
2001 Science
The Spectrum of Vasculitis
1978 Standout
Intravenous immunoglobulin for Guillain-Barré syndrome
2014
Intravenous gamma globulin in the treatment of chronic idiopathic thrombocytopenic purpura in adults
1984
Current Options for the Treatment of Idiopathic Thrombocytopenic Purpura
2007
Glutathione S-Transferases
1974 Standout
Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology [see comments]
1996 Standout
EFFECT OF INTRAVENOUS IMMUNOGLOBULIN IN IMMUNE THROMBOCYTOPENIA
1983
The C-type lectin SIGN-R1 mediates uptake of the capsular polysaccharide ofStreptococcus pneumoniaein the marginal zone of mouse spleen
2003 StandoutNobel
Fc receptors in antibody‐dependent enhancement of viral infections
2015
Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2
2020 Standout
WEGENER'S GRANULOMATOSIS
1995
The nontreatment of childhood idiopathic thrombocytopenic purpura
1987
Intravenous Immunoglobulin: Striving for Appropriate Use
2006
Reversal of Chronic Polymyositis Following Intravenous Immune Serum Globulin Therapy
1987
Intravenous immunoglobulin administration in the treatment of severe chronic immune thrombocytopenic purpura
1984
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association
2004 Standout
Polymyalgia Rheumatica
1965
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group
2008 Standout
Intravenous Anti-D Treatment of Immune Thrombocytopenic Purpura: Experience in 272 Patients
1997
Treatment of acute idiopathic thrombocytopenia of childhood with intravenous infusions of gammaglobulin
1985
Intravenous gammaglobulin (Gamimune) for treatment of chronic idiopathic thrombocytopenic purpura (ITP): A two‐year follow‐up
1986
Plasma and gamma-globulin infusion in chronic inflammatory polyneuropathy
1985
Idiopathic thrombocytopenia, initial illness and long term follow up.
1984
IMMUNOLOGY OF MULTIPLE SCLEROSIS
2005 Standout
Treatment of Refractory Immune Thrombocytopenic Purpura with an Anti-Fcγ-Receptor Antibody
1986
Kawasaki Disease: A Brief History
2000
Intravenous Treatment with Gammaglobulin in Adults with Immune Thrombocytopenic Purpura: Review of the Literature1
1987
Site-specific chemical modification of recombinant proteins produced in mammalian cells by using the genetically encoded aldehyde tag
2009 StandoutNobel
The Treatment of Kawasaki Syndrome with Intravenous Gamma Globulin
1986 Standout
HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR KAWASAKI DISEASE
1984
Treatment of Adult Autoimmune Thrombocytopenic Purpura with High‐Dose Intravenous Plasmin‐Cleaved Gammaglobulins
1983
Intravenous use of gammaglobulin in the treatment of chronic immune thrombocytopenic purpura as a means to defer splenectomy
1983
Intravenous immunoglobulin: Historical perspective
1987
Long-term Consequences of Kawasaki Disease
1996 Standout
Intravenous anti-D treatment of immune thrombocytopenic purpura: analysis of efficacy, toxicity, and mechanism of effect [see comments]
1991
Treatment of adult chronic autoimmune thrombocytopenic purpura with repeated high-dose intravenous immunoglobulin
1993
Revised guidelines for the control of methicillin-resistant Staphylococcus aureus infection in hospitals
1998
ANTI-IDIOTYPIC SUPPRESSION OF AUTOANTIBODIES TO FACTOR VIII (ANTIHAEMOPHILIC FACTOR) BY HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN
1984
A randomized and comparative study of intravenous immunoglobulin and mega dose methylprednisolone treatments in children with acute idiopathic thrombocytopenic purpura.
2004
Safety and efficacy of long-term treatment with romiplostim in thrombocytopenic patients with chronic ITP
2008
Maintenance treatment of adults with chronic refractory immune thrombocytopenic purpura using repeated intravenous infusions of gammaglobulin [see comments]
1988
Intensive plasma exchange therapy in ten patients with idiopathic thrombocytopenic purpura
1984
Pyridine nucleotides in erythrocyte metabolism.
1966
Treatment of childhood idiopathic thrombocytopenic purpura with Rhesus antibodies (anti-D)
1986
A Randomized Trial Comparing Intravenous Immune Globulin and Plasma Exchange in Guillain–Barré Syndrome
1992 Standout
Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation
2006 Science
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease
2004 Standout
Long‐Term Follow‐Up Study of 168 Patients with Immune Thrombocytopenia. Implications for Therapy
1984
Control of Glycolysis in the Human Red Blood Cell
1966 StandoutNobel
Conjugations with glutathione. Distribution of glutathione S-aryltransferase in vertebrate species
1964
Response of Resistant Idiopathic Thrombocytopenic Purpura to Pulsed High-Dose Dexamethasone Therapy
1994
Age-related differences in salicylamide and acetaminophen conjugation in man
1977 StandoutNobel
Physiologic Jaundice: The Enterohepatic Circulation of Bilirubin
1971
Effects of intravenous immunoglobulin on platelet count and antiplatelet antibody disposition in a rat model of immune thrombocytopenia
2002
The relationship between hepatic glutathione conjugation and BSP excretion and the effect of therapeutic agents
1967
Diversity of Antiviral IgG Effector Activities Observed in HIV-Infected and Vaccinated Subjects
2016
Bilirubin Metabolism and Kernicterus
1997
Leukemia and other Cancers, Anomalies and Infections as Causes of Death in Down's Syndrome in the United States during 1976
1982
Effects of aspartic acid, orotic acid, and glucose on serum bilirubin concentrations in infants born before term.
1971
MANAGEMENT OF CHILDHOOD IDIOPATHIC THROMBOCYTOPENIC PURPURA
1983
Takayasu's Arteritis and Ankylosing Spondylitis Report of Four Cases
1966
Bilirubin Metabolism with Special Reference to Neonatal Jaundice
1962
Surgery of the Spleen
1983
Treatment of acute idiopathic thrombocytopenic purpura of childhood with intravenous immunoglobulin G: Comparative efficacy of 7S and 5S preparations
1986
Takayasu's Arteritis
1967 Standout
Works of M Vest being referenced
Conjugation Reactions in the Newborn Infant: The Metabolism of Para-aminobenzoic Acid
1965
Erythrocyte survival in the newborn infant, as measured by chromium51 and its relation to the postnatal serum bilirubin level
1961
CONJUGATION OF SULFOBROMOPHTHALEIN IN NEWBORN INFANTS AND CHILDREN
1962
DETOXIFICATION IN THE NEWBORN: THE ABILITY OF THE NEWBORN INFANT TO FORM CONJUGATES WITH GLUCURONIC ACID, GLYCINE, ACETATE AND GLUTATHIONE
1963
Studies on Glucuronide Formation in Newborn Infants and Older Children
1959
The Extent of ‘Shunt’ Bilirubin and Erythrocyte Survival in the Newborn Infant Measured by the Administration of [15N]Glycine
1965
Insufficient Glucuronide Formation in the Newborn and its Relationship to the Pathogenesis of Icterus Neonatorum
1958
HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDHOOD
1981 Standout